Figure 2.
PK Profile of AKR-001 in Type 2 Diabetic Patients
(A and B) Median serum concentration of intact AKR-001 following (A) weekly (QW) and (B) once every 2 weeks (Q2W) dose regimens.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.